Clinical Trials Directory

Trials / Completed

CompletedNCT01113554

Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors

A Pilot Study to Evaluate the Feasibility of a Breast Cancer Rehabilitation Program in Survivors of Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: A breast cancer rehabilitation program and exercise therapy may help improve the quality of life of breast cancer survivors. PURPOSE: This clinical trial studies a breast cancer rehabilitation program in improving quality of life in breast cancer survivors.

Detailed description

PRIMARY OBJECTIVES: I. To estimate accrual, retention, adherence, and participation of breast cancer survivors to a breast cancer rehabilitation program. II. To estimate the variability of weight, six-minute walk, quality of life and other psychosocial and physical measures in women participating in the BCRP. SECONDARY OBJECTIVES: I. To assess changes in the anthropometric, psychosocial, and physical outcomes over the six-month period of the BCRP. II. To document the types and the rates of adverse events associated with the BCRP. OUTLINE: Patients attend exercise therapy sessions over 1 hour 3 times a week for 6 months. Exercise therapy sessions are comprised of a 10 minute warm-up of light stretching and aerobic type exercise (walking, cycling), 30 minutes of endurance type exercise (cycle, walking), and 20 minutes of resistance training exercise.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaire administration
BEHAVIORALexercise intervention
PROCEDUREquality-of-life assessment
OTHERsurvey administration
PROCEDUREmanagement of therapy complications
PROCEDUREpsychosocial assessment and care

Timeline

Start date
2010-06-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2010-04-30
Last updated
2018-07-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01113554. Inclusion in this directory is not an endorsement.